Approach to Address Limited Supply of BCG (OncoTICE)

By Tammy Northman | Latest news and stories | Comments are Closed | 12 November, 2018 | 0

Bladder Cancer Canada and its Medical Advisory Board have been advised by Merck Canada that they will be experiencing limited supply of Bacillus Calmette-Guerin (BCG) in the coming months.

Merck has established an allocation plan effective immediately and will keep information updated at https://www.drugshortagescanada.ca/drug/4066

Merck expects to fulfill between 75% and 100% of the normal demand during this time. Allocation based on historical customer orders has been implemented to ensure the available quantity is efficiently provided to patients. The anticipated end date is October 2019.

Below is an approach for consideration by physicians who treat bladder cancer to address the shortage of BCG should limited supply be realized.

Download the document here: Approach to Address BCG Shortage (Nov 2018)

The Medical Advisory Board of Bladder Cancer Canada and the CUA Guidelines Committee have reviewed and support these suggestions.

Bladder Cancer Canada will continue to update you as we receive more information.

No tags.

OTTAWA EDUCATION MEETING YIELDS VALUABLE INFORMATION AND RESOURCES

By Kerrya | Comments are Closed

Bladder Cancer Canada welcomed 80 patients, caregivers and family members to our Patient Education Meeting in Ottawa on November 21. We were fortunate to learn from three dynamic presenters and a panel of inspiring bladderRead more
Halifax Patient Meeting – Photo Slideshow

By Kerrya | Comments are Closed

https://bladdercancercanada.org/wp-content/uploads/2018/11/Fergs-video-of-Halifax-Pt-Mt-photos.mp4Read more
WEBINAR RECORDING – SEXUALITY AND INTIMACY WHEN FACING BLADDER CANCER

By Kerrya | Comments are Closed

On November 28, 2018, Bladder Cancer Canada was fortunate to be able to partner with Janet Giroux (Nurse Practitioner from Kingston General Hospital’s Cancer Centre Sexual Health Clinic) to present a webinar on “Sexuality andRead more
Dr. Peter Black, Professor at UBC, awarded $50,000 Bladder Cancer Canada Research Grant

By Kerrya | Comments are Closed

The Project: Proteomics Analysis of Chemoresistance in Bladder Cancer Twenty-five percent of patients with bladder cancer are diagnosed with muscle invasive disease. These patients usually receive chemotherapy followed by surgery to remove the bladder. UpRead more
BCC Awareness Walk – Social Media Tool Kit

By Kerrya | Comments are Closed

Did you know that in an average peer-to-peer fundraising campaign (like the BCC Awareness Walk), about 18% of donations are referred directly from Facebook alone? Social media is arguably one of the most efficient mechanismsRead more
Helpful exercises for bladder cancer patients

By Kerrya | Comments are Closed

As part of our recent webinar “Living well with bladder cancer and beyond”, Amy Sweeney – Registered Kinesiologist, presented on the importance of exercise for bladder cancer patients. As a follow-up to her presentation, she provided aRead more
Ferg Devins appointed Board Chair June 15th, Ken Bagshaw moved to Past Chair

By Maryse Tremblay | Comments are Closed

TORONTO – June 15, 2018: Bladder Cancer Canada’s national board of directors has advised that Ferg Devins, bladder cancer survivor and former National Walk Lead of Bladder Cancer Canada’s September awareness walk took the reinsRead more
JOIN AN AWARENESS WALK – Post

By Randy Olson | Comments are Closed

BLADDER CANCER CANADA AWARENESS WALK The walk is one of Bladder Cancer Canada’s (BCC) main sources of funding, but also serves as a vehicle to spread awareness and as a venue to bring those affectedRead more